Jin Medical International Ltd's Comment on Sales, Marketing and Customers
Changzhou Zhongjin primarily serves customers in Japan and China, offering higher-end wheelchairs for the Japanese market and lower-end wheelchairs and components for the Chinese market. The company’s products address market trends such as increased spending power, growing popularity of active lifestyles among disabled individuals, and an aging population. Changzhou Zhongjin manufactures lightweight, ergonomic wheelchairs customized to end users' specifications and distributes them mainly through a network of qualified dealers, including over forty distributors in China and more than twenty in other regions.
A key customer is Nissin Medical Industries Co., Ltd ("Nissin"), the largest dealer and sole distributor in Japan since 2006, which accounted for approximately 58.6%, 47.6%, and 69.8% of Changzhou Zhongjin’s revenues for the fiscal years 2025, 2024, and 2023, respectively. Additionally, Nissin’s wholly-owned subsidiaries—Colours’n Motion Inc ("Colors"), Nissin Co., Ltd. ("Nissin Korea"), and Nissin Medical Vietnam Co., Ltd. ("Nissin Vietnam")—contributed 12.4%, 9.7%, and 8.4% of total revenue for the same fiscal years. All products sold to Nissin are original equipment manufacturer (OEM) products made to Nissin’s specifications and sold under Nissin’s brands in Japan. Nissin was the only customer representing more than 10% of revenue in the fiscal years ended September 30, 2025, 2024, and 2023.
Jin Medical International Ltd’s Comment on Sales, Marketing and Customers
Changzhou Zhongjin primarily serves customers in Japan and China, offering higher-end wheelchairs for the Japanese market and lower-end wheelchairs and components for the Chinese market. The company’s products address market trends such as increased spending power, growing popularity of active lifestyles among disabled individuals, and an aging population. Changzhou Zhongjin manufactures lightweight, ergonomic wheelchairs customized to end users' specifications and distributes them mainly through a network of qualified dealers, including over forty distributors in China and more than twenty in other regions.
A key customer is Nissin Medical Industries Co., Ltd ("Nissin"), the largest dealer and sole distributor in Japan since 2006, which accounted for approximately 58.6%, 47.6%, and 69.8% of Changzhou Zhongjin’s revenues for the fiscal years 2025, 2024, and 2023, respectively. Additionally, Nissin’s wholly-owned subsidiaries—Colours’n Motion Inc ("Colors"), Nissin Co., Ltd. ("Nissin Korea"), and Nissin Medical Vietnam Co., Ltd. ("Nissin Vietnam")—contributed 12.4%, 9.7%, and 8.4% of total revenue for the same fiscal years. All products sold to Nissin are original equipment manufacturer (OEM) products made to Nissin’s specifications and sold under Nissin’s brands in Japan. Nissin was the only customer representing more than 10% of revenue in the fiscal years ended September 30, 2025, 2024, and 2023.
Sources:
Jin Medical International Ltd’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Jin Medical International Ltd’s corporate clients.
For your research, we’ve provided 9 tables on Jin Medical International Ltd corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
